First Horizon Advisors, Inc. Morpho Sys Ag Transaction History
First Horizon Advisors, Inc.
- $3.28 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding MOR
# of Institutions
43Shares Held
1.84MCall Options Held
79.8KPut Options Held
688K-
Black Rock Inc. New York, NY1.02MShares$00.0% of portfolio
-
Segantii Capital Management LTD463KShares$01.04% of portfolio
-
Tekla Capital Management LLC177KShares$00.05% of portfolio
-
Hennion & Walsh Asset Management, Inc.125KShares$00.12% of portfolio
-
Engineers Gate Manager LP New York, NY13.4KShares$00.01% of portfolio
About MorphoSys AG
- Ticker MOR
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 136,614,000
- Description
- MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...